
Joshua Caleb Leinwand MD
Surgical Oncology (Other than Breast)
Physician
Join to View Full Profile
425 W 59th St7th FloorNew York, NY 10019
Phone+1 212-523-8887
Fax+1 212-523-8857
Dr. Leinwand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joshua Leinwand is a general surgeon based in New York, NY, with a subspecialty in surgical oncology, excluding breast cancer. He graduated from Yale School of Medicine in 2013. His research includes notable publications focusing primarily on pancreatic cancer and immune responses, featured in journals like Oncogene, The Journal of Clinical Investigation, The Journal of Experimental Medicine, and Cancer Cell. Some of his work has garnered significant citations, reflecting engagement with the broader scientific community.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2022 - 2024
- New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 2013 - 2022
- Yale School of MedicineClass of 2013
Certifications & Licensure
- NY State Medical License 2021 - 2027
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 1 citationsCorrection to: BTLACD200B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer.Brian Diskin, Salma Adam, Gustavo Sanchez Soto, Miguel Liria, Berk Aykut
Oncogene. 2023-02-01 - 6 citationsBTLACD200B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer.Brian Diskin, Salma Adam, Gustavo Sanchez Soto, Miguel Liria, Berk Aykut
Oncogene. 2022-09-01 - 38 citationsIntrahepatic microbes govern liver immunity by programming NKT cells.Joshua C Leinwand, Bidisha Paul, Ruonan Chen, Fangxi Xu, Maria A Sierra
The Journal of Clinical Investigation. 2022-04-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: